Overview
- 7 inspections across 7 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-02-02.
At a glance
Inspections
7
Sites
7
Observations
0
Career since
Feb 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Houston, Inc | 2 Feb 2024 | Biologics | |
| Juno Therapeutics, Inc. | 16 Oct 2020 | Biologics | On file |
| Spark Therapeutics, Inc. | 25 Aug 2017 | Biologics | On file |
| Biovex Incorporated | 13 Feb 2015 | Biologics | On file |
| AGC Biologics, Inc. | 6 Jun 2014 | Biologics | On file |
Sites inspected
Lonza Houston, IncHouston, United States1 insp.
Juno Therapeutics, Inc.Bothell, United States1 insp.
Spark Therapeutics, Inc.Philadelphia, United States1 insp.
Biovex IncorporatedWoburn, United States1 insp.
AGC Biologics, Inc.Bothell, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nirjal Bhattarai2 shared
Deborah M Trout2 shared
Pankaj K Mandal1 shared
Phillip C Thai1 shared
David E Bailey1 shared
Kimberly L Schultz1 shared
Prabhu P Raju1 shared
Eileen A Liu1 shared
Nancy T Waites1 shared
Mihaly S Ligmond1 shared
Full investigator report
Get the verbatim findings behind Rabia Ballica's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site